SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-003528
Filing Date
2023-02-03
Accepted
2023-02-03 16:05:40
Documents
15
Period of Report
2023-01-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39605
2 ex10-1.htm EX-10.1 2223
3 ex10-1_001.jpg GRAPHIC 784453
4 ex10-1_004.jpg GRAPHIC 123749
  Complete submission text file 0001493152-23-003528.txt   1465420

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ocx-20230130.xsd EX-101.SCH 3224
6 XBRL LABEL FILE ocx-20230130_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE ocx-20230130_pre.xml EX-101.PRE 22358
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3461
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 23585760
SIC: 2835 In Vitro & In Vivo Diagnostic Substances